Trials / Conditions / Endometrial Mixed Adenocarcinoma
Endometrial Mixed Adenocarcinoma
4 registered clinical trials studyying Endometrial Mixed Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer NCT01737619 | M.D. Anderson Cancer Center | N/A |
| Completed | Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer NCT01642082 | Gynecologic Oncology Group | Phase 2 |
| Completed | Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer NCT00888173 | Gynecologic Oncology Group | Phase 2 |
| Completed | Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV En NCT00575952 | Gynecologic Oncology Group | Phase 1 |